JPRN-UMIN000005381尚未招募2 期
eoaduvant chemotherapy woth FOLFOXIRI and anti-EGFR monoclonal antibody for colorectal cancer with liver metastasis - Neoaduvant chemotherapy woth FOLFOXIRI and anti-EGFR monoclonal antibody for colorectal cancer with liver metastasis
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)had a previous serious medical illness or allergy for drugs 2)had active double cancer 3)had a hypersensitivity or taboo for test drugs 4)had active infection disease(oner 38.0C fever) 5)had serious complication(ireus,renal function,liver function,heart failure,diabetes within could not control) 6)had serious bowel blockage 7)had serious interstitinal fibrosis 8)had pleural effusion or abdominal dropsy within could not control 9)had watersolubility diarrhea 10)had brain metastasis 11)pregnant or lactating woman,woman who are capable of pregnancy or intend to get pregnant,man who are not inend to contraception 12)had mental illness 13)expect referred to above physician in charge of this trial gave a diagnosis the patient who can not join this trial for the safety
研究者
相似试验
招募中
2 期
Induction chemotherapy for locally advanced rectal cancer.2023-509758-74-00Catharina Ziekenhuis Stichting128
招募中
1 期
Induction chemotherapy for locally advanced rectal cancer.ocally advanced rectal cancerMedDRA version: 20.0Level: PTClassification code: 10038038Term: Rectal cancer Class: 100000004864CTIS2023-509758-74-00Catharina Ziekenhuis Stichting128
招募中
2 期
eo-adjuvant FOLFOXIRI and chemoradiotherapy for high risk (*ugly*) locally advanced rectal cancer.High risk locally advanced rectal cancerrectal cancer of a locally advanced stage1001799110017998NL-OMON52634Catharina-ziekenhuis128
进行中（未招募）
不适用
Folfiri as Second-Line chemotherapy for Advanced Pancreatic cancer:a GISCAD Phase II study - SLAP (Second Line Advanced Pancreas)Subjects enrolled in this study must have histologically confirmed locally advanced or metastatic pancreatic adenocarcinoma. They must have been received a first-line chemotherapy (one line only) with Gemcitabin +/Platinoid(Cisplatin,Oxaliplatin,Carboplatin)MedDRA version: 14.1Level: LLTClassification code 10013250Term: Disorder pancreasSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2008-004637-16-ITGISCAD
进行中（未招募）
不适用
Perioperative chemotherapy with FOLFOX plus Cetuximab versus adjuvant FOLFOX plus Cetuximab for patients with resectable liver metastases of colorectal carcinoma - Panter-studyresectable liver metastases of colorectal carcinoma with proven K-RAS wildtypeEUCTR2008-005312-41-ATRWTH Aachen University430